Bridgewater Associates’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Bridgewater Associates's ASND Position: Q3 2026 in Review
Bridgewater Associates opened a new position in Ascendis Pharma (ASND) in Q3 2026: 19,296 shares worth $4.4M. The stake represents 0.02% of the portfolio and ranks #580 among its holdings.
347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Bridgewater Associates held 19,296 shares of Ascendis Pharma worth $4.4M as of Q3 2026.
- Ascendis Pharma was a new Bridgewater Associates position in Q3 2026.
- Ascendis Pharma made up 0.02% of Bridgewater Associates's portfolio in Q3 2026, its #580 holding.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.